Jennifer Champoux, Chief Operating Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 4,351 shares at $23.38 ($102K) on 2026-07-15, disclosed to the SEC on 2026-07-16.
Scheduled sale ($102k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2026-05-28 | $44K | — | Filing → |
| GLUE | SELL | 2026-05-26 | $41K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $40K | — | Filing → |